Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma

Abstract
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Liang Hu1, 6, *, Ruo-Yu Wang2, *, Jian Cai3, *, Dan Feng4, *, Guang-Zhen Yang5, Qing-Guo Xu2, Yan-Xia Zhai1, Yu Zhang1, Wei-Ping Zhou2, Qing-Ping Cai6 1Anal-Colorectal Surgery Institute, 150th Hospital of PLA, Luoyang, China 2The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China 3Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China 4Department of Oncology, Changhai Hospital, Second Military Medical University, Shanghai, China 5Department of Clinical Laboratory, 150th Hospital of PLA, Luoyang, China 6Department of Gastrointestine Surgery, Changzheng Hospital, Second Military Medical University, Shanghai, China *These authors contributed equally to this work Correspondence to: Liang Hu, email: lianghudoc@163.com Qing-Ping Cai, email: caiqingpingwcwk@163.com Keywords: CHKA, colorectal carcinoma, progression, prognosis, biomarker Received: January 06, 2016 Accepted: August 13, 2016 Published: August 20, 2016